InvestorsHub Logo
Followers 1053
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Tuesday, 09/08/2015 4:58:46 PM

Tuesday, September 08, 2015 4:58:46 PM

Post# of 43382
http://seekingalpha.com/article/2970526-gerons-gern-ceo-john-scarlett-on-q4-2014-results-earnings-call-transcript?page=3

" we are conducting a business development effort to explore, identify and perform diligence reviews of potentially promising oncology product candidate programs and/or companies that if acquired or partnered by Geron may allow the company to diversify its development portfolio".

KBIO?

"KaloBios is open to partnering its programs with partners who share out commitment to advancing our Humaneered® antibodies. These partners should share our commitment to advancing our Humaneered® monoclonal antibodies so that patients may benefit from these medicines. Given the stage of these programs, we seek partners that recognize innovation, strive for excellence, and have strong expertise in mid-to-late stage development, regulatory approval and commercialization of monoclonal antibodiesin the indications being pursued."


My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.